Alligator Bioscience AB (publ) (STO:ATORX)
0.1786
-0.0128 (-6.69%)
Jun 11, 2026, 5:29 PM CET
Alligator Bioscience AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.98 | 62.2 | 64.31 | 66.12 | 97.31 | 278.15 |
Cash & Short-Term Investments | 32.98 | 62.2 | 64.31 | 66.12 | 97.31 | 278.15 |
Cash Growth | 14.31% | -3.28% | -2.73% | -32.05% | -65.02% | 169.15% |
Accounts Receivable | - | - | 0.52 | 0 | 13.93 | 7.45 |
Other Receivables | 3.72 | 5.77 | 4.93 | 9.34 | 4.54 | 8.86 |
Receivables | 3.72 | 5.77 | 5.45 | 9.34 | 18.47 | 16.31 |
Prepaid Expenses | 16.65 | 0.7 | 1.64 | 2.73 | 7.04 | 5.16 |
Other Current Assets | - | - | - | - | 0 | - |
Total Current Assets | 53.36 | 68.66 | 71.4 | 78.19 | 122.81 | 299.61 |
Property, Plant & Equipment | 1.6 | 1.87 | 3.02 | 20.31 | 26.94 | 15.42 |
Other Intangible Assets | 40.07 | 40.07 | 27.87 | 17.96 | 18.02 | 18.17 |
Other Long-Term Assets | -0 | - | 2.06 | 1.99 | 1.82 | 0 |
Total Assets | 95.02 | 110.6 | 104.34 | 118.45 | 169.58 | 333.2 |
Accounts Payable | 4.46 | 4.58 | 3.95 | 21.27 | 13.34 | 9.37 |
Accrued Expenses | 11.04 | 12.87 | 42.49 | 63.3 | 38.62 | 13.42 |
Short-Term Debt | - | 8.34 | 137.24 | - | - | - |
Current Portion of Leases | 9 | 9.21 | 10.1 | 8.58 | 8.5 | 6.23 |
Current Unearned Revenue | - | 0.11 | 0.76 | 0.56 | 0.77 | 6.56 |
Other Current Liabilities | 5.86 | 43.04 | 6.92 | 5.37 | 3.3 | 11.85 |
Total Current Liabilities | 30.36 | 78.15 | 201.45 | 99.08 | 64.53 | 47.42 |
Long-Term Leases | 23.38 | 25.6 | 33.48 | 7.52 | 16 | 3.51 |
Other Long-Term Liabilities | -0 | - | - | - | 0 | - |
Total Liabilities | 53.74 | 103.74 | 234.93 | 106.6 | 80.53 | 50.93 |
Common Stock | 125.62 | 8.76 | 0.61 | 42.17 | 88.61 | 88.23 |
Additional Paid-In Capital | 1,213 | 1,301 | 1,147 | 1,055 | 911.9 | 911.83 |
Retained Earnings | -1,298 | -1,303 | -1,278 | -1,086 | -911.46 | -717.79 |
Comprehensive Income & Other | - | - | - | - | -0 | - |
Shareholders' Equity | 41.28 | 6.86 | -130.59 | 11.86 | 89.05 | 282.27 |
Total Liabilities & Equity | 95.02 | 110.6 | 104.34 | 118.45 | 169.58 | 333.2 |
Total Debt | 32.38 | 43.15 | 180.81 | 16.1 | 24.5 | 9.74 |
Net Cash (Debt) | 0.6 | 19.05 | -116.5 | 50.02 | 72.8 | 268.41 |
Net Cash Growth | - | - | - | -31.29% | -72.88% | 194.09% |
Net Cash Per Share | 0.00 | 0.69 | -158.66 | 111.53 | 330.05 | 2993.33 |
Filing Date Shares Outstanding | 628.11 | 43.81 | 0.76 | 0.66 | 0.22 | 0.22 |
Total Common Shares Outstanding | 628.11 | 43.81 | 0.76 | 0.66 | 0.22 | 0.22 |
Working Capital | 22.99 | -9.48 | -130.06 | -20.89 | 58.29 | 252.2 |
Book Value Per Share | 0.07 | 0.16 | -172.23 | 18.02 | 403.70 | 1279.66 |
Tangible Book Value | 1.21 | -33.21 | -158.45 | -6.11 | 71.03 | 264.11 |
Tangible Book Value Per Share | 0.00 | -0.76 | -208.98 | -9.28 | 322.02 | 1197.30 |
Machinery | - | 1.81 | 34.83 | 34.83 | 32.37 | 31.93 |
Leasehold Improvements | - | - | - | - | - | 3.07 |